| Structure | Chemical Name | CAS | MF |
|
10,10-dimethyl-2,6-bis(methylene)bicyclo[7.2.0]undecan-5-ol
|
38284-26-3
|
C15H24O
|
|
3,5-octadienone,3,5-octadien-2-one
|
38284-27-4
|
C8H12O
|
|
Bicyclo[3.1.0]hexane-6-carboxylic acid, methyl ester, (1alpha,5alpha,6alpha)- (9CI)
|
38284-36-5
|
C8H12O2
|
|
4-bicyclo[2.2.1]hept-5-en-2-yl-3-methyl-3-buten-2-one
|
38284-38-7
|
C12H16O
|
|
3-(bicyclo[2.2.1]hept-5-en-2-yl)methacrylaldehyde
|
38284-42-3
|
C11H14O
|
|
2-(bicyclo[2.2.1]hept-5-en-2-ylmethylene)hexenal
|
38284-44-5
|
C14H18O
|
|
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine
|
38284-47-8
|
C17H31NO2
|
|
G 111
|
38285-26-6
|
|
|
(E)-3-Nonen-2-ol
|
38285-42-6
|
C9H18O
|
|
TEPYL ACETATE
|
38285-49-3
|
C12H22O3
|
|
DIMETHYL 3,3'-DITHIO-BIS(PROPIONIMIDATE) DIHYDROCHLORIDE
|
38285-78-8
|
C8H17ClN2O2S2
|
|
Cyclohexanecarboxylic acid, 5-cyano-2-oxo-5-phenyl-, Methyl ester
|
38289-20-2
|
C15H15NO3
|
|
trans-4-Propylcyclohexanecarboxylic acid
|
38289-27-9
|
C10H18O2
|
|
trans-4-Butylcyclohexanecarboxylic acid
|
38289-28-0
|
C11H20O2
|
|
trans-4-Pentylcyclohexanecarboxylic acid
|
38289-29-1
|
C12H22O2
|
|
trans-4-Hexylcyclohexanecarboxylic acid
|
38289-30-4
|
C13H24O2
|
|
trans-4-Heptylcyclohexanecarboxylic acid
|
38289-31-5
|
C14H26O2
|
|
trans-4-octylcyclohexane carboxylic acid
|
38289-32-6
|
C15H28O2
|
|
4-N-NONYLBENZOIC ACID
|
38289-46-2
|
C16H24O2
|
|
2α,3β,19α-Trihydroxyoleana-12-ene-23,28-dioic acid
|
38290-00-5
|
C30H46O7
|
|
(14R)-6β,14-Diacetoxygrayanotoxane-2α,3β,5,10,16-pentol
|
38290-01-6
|
C24H38O9
|
|
chlorohyssopifolin B
|
38290-03-8
|
C15H19ClO5
|
|
3,4,7,8-Tetrahydro-5-hydroxy-2,3-dimethyl-8-(3-methyl-2-butenyl)-8-[5-methyl-2-(1-methylethenyl)-4-hexenyl]-4,7-dioxo-β-phenyl-2H-1-benzopyran-6-propionic acid
|
38290-04-9
|
C35H44O6
|
|
(6aR)-10,11-Dimethoxy-4,5,6a,7-tetrahydro-6-methyl-6H-dibenzo[de,g]quinoline
|
38291-33-7
|
|
|
VALERIC ACID HYDRAZIDE
|
38291-82-6
|
C5H12N2O
|
|
1,18-bis(Hydrazinocarbonyl)octadecane
|
38291-94-0
|
|
|
tyrosine glucoside
|
38292-17-0
|
|
|
1,2-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE
|
38292-40-9
|
C11H11NO
|
|
2-Benzothiazolecarbonitrile,6-(acetyloxy)-(9CI)
|
38292-82-9
|
C10H6N2O2S
|
|
4-OXOTETRAHYDROTHIOPHENE-2,3-DICARBOXYLIC ACID DIMETHYL ESTER
|
38293-63-9
|
C8H10O5S
|
|
methyl 3-[(2-methoxy-2-oxoethyl)sulfanyl]-2-methylpropanoate
|
38293-65-1
|
C8H14O4S
|
|
α-Chloroacetophenone 2,4-dinitrophenyl hydrazone
|
38293-71-9
|
C14H11ClN4O4
|
|
Phenol, 4,4-(1-methylethylidene)bis-, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine and (chloromethyl)oxirane
|
38294-64-3
|
C28H43ClN2O3
|
|
Phenol, 4,4-(1-methylethylidene)bis-, polymer with N,N-bis(2-aminoethyl)-1,2-ethanediamine and (chloromethyl)oxirane
|
38294-69-8
|
C24H39ClN4O3
|
|
POTASSIUM HEXANITRORHODATE(III)
|
38295-15-7
|
K3N6O12Rh
|
|
aurio sodium thiosulphate
|
38295-16-8
|
AuH3NaO3S2
|
|
2-Propenoic acid, 2-methyl-, polymer with ethenylbenzene, methyl 2-methyl-2-propenoate and 2-methylpropyl 2-methyl-2-propenoate
|
38298-19-0
|
C25H36O6
|
|
tyrosine-4-azophenyltrimethylammonium chloride
|
38299-26-2
|
|
|
4-N-DECYLBENZOIC ACID
|
38300-04-8
|
C17H26O2
|
|
1,12-Cyclodocosanedione
|
38300-52-6
|
|
|
1,2,4-Tribromobutane
|
38300-67-3
|
C4H7Br3
|
|
1-Butanol, 4-chloro-2-methyl-
|
38300-73-1
|
C5H11ClO
|
|
[2S-(1alpha,2alpha,4alpha,6alpha)]-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane
|
38301-46-1
|
C10H17O
|
|
(23R)-16α,23-Epoxy-5α-lanosta-8,24-dien-3α-ol
|
38301-91-6
|
C30H48O2
|
|
(23R)-16α,23-Epoxy-5α-lanosta-8,24-dien-3-one
|
38301-93-8
|
C30H46O2
|
|
(23R)-16α,23-Epoxy-5α-lanosta-8,24-dien-3β-ol
|
38301-94-9
|
C30H48O2
|
|
Naringenin trimethyl ether
|
38302-15-7
|
C18H18O5
|
|
(2S,10aα,11aα,12R)-Tetradecahydro-3,3,7-trimethyl-11-methylene-5aβ,8β-methano-5aH-cyclohepta[b]naphthalene-2α,4α,4aβ,7β,12-pentol
|
38302-26-0
|
C20H32O5
|
|
(2S,12R)-1,2,3,4,4a,5,8,9,10,10aα,11,11aα-Dodecahydro-3,3,7-trimethyl-11-methylene-5aβ,8β-methano-5aH-cyclohepta[b]naphthalene-2,4α,4aβ,12-tetrol
|
38302-27-1
|
C20H30O4
|
|
4,5,6,7,8,9,10,11,12,13-decahydrocyclododecaoxazole
|
38303-23-0
|
C5H13N11O11
|
|
1,8-Dibromopyrene
|
38303-35-4
|
C16H8Br2
|
|
1,3,6-tribromopyrene
|
38303-36-5
|
C16H7Br3
|
|
Azulene-1,3-dicarboxylic acid
|
38303-39-8
|
|
|
sodium hydrogen octylphosphonate
|
38304-27-7
|
C8H18NaO3P
|
|
disodium octylphosphonate
|
38304-28-8
|
C8H17Na2O3P
|
|
3,3'-[2-(oxiranylmethoxy)propane-1,3-diyl]bis[5,5-dimethyl-1-(oxiranylmethyl)imidazolidine-2,4-dione]
|
38304-52-8
|
C22H32N4O8
|
|
(6,7-dimethoxy-3-methyl-benzofuran-2-yl)-morpholin-4-yl-methanone
|
38304-79-9
|
C16H19NO5
|
|
Minoxidil
|
38304-91-5
|
C9H15N5O
|
|
propyl-3-sarcolysin-4-fluorophenylalanine
|
38305-84-9
|
C27H33Cl2FN4O4
|
|
9-(naphthalen-2-ylsulfinylmethyl)fluoren-9-ol
|
38306-17-1
|
C24H18O2S
|
|
Boc-DL-hoMoserine
|
38308-92-8
|
C9H17NO5
|
|
3H-SPIRO[2-BENZOFURAN-1,4'-PIPERIDINE]
|
38309-60-3
|
C12H15NO
|
|
2,7-BIS(BROMOMETHYL)NAPHTHALENE
|
38309-89-6
|
C12H10Br2
|
|
1,2-Dihydro-2,2,4-trimethyl-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(1,1,3-trimethyl-1H-cyclopenta[b]quinoxalin-2-yl)-1,3,5,7,9,11,13,15,17-octadecanonenyl]phenazine
|
38310-09-7
|
C51H54N4
|
|
2a,8b-Dihydrocyclopent[cd]azulene
|
38310-40-6
|
C12H10
|
|
(1α,2α,4α,5α)-8-Methylenetricyclo[3.2.1.02,4]octane
|
38310-48-4
|
C9H12
|
|
11BETA-PROSTAGLANDIN E2
|
38310-90-6
|
C20H32O5
|
|
Ethanone, 1-tetracyclo[3.3.0.02,8.03,6]oct-4-yl-, stereoisomer (9CI)
|
38311-27-2
|
C10H12O
|
|
Ethanone, 1-tetracyclo[3.3.0.02,8.03,6]oct-4-yl-, stereoisomer (9CI)
|
38311-28-3
|
C10H12O
|
|
1,8-Dibromo-9,10-anthraquinone
|
38313-16-5
|
C14H6Br2O2
|
|
M-8
|
38313-28-9
|
C11H16BrNO2
|
|
3',5'-Anhydrothymidine
|
38313-48-3
|
C10H12N2O4
|
|
diboron europium tetraoxide
|
38313-81-4
|
B2EuH6O4-5
|
|
8-Chloro-1,2,3,4-tetrahydro-1-[(4-methylphenyl)sulfonyl]-5H-1-benzazepin-5-one
|
38314-49-7
|
C17H16ClNO3S
|
|
1-Methyl-6-nitro-9H-pyrido[3,4-b]indole
|
38314-91-9
|
|
|
(7ξ)-Ophiobola-3,15-diene-7,18-diol
|
38315-20-7
|
C25H42O2
|
|
(4R)-9-Hydroxykaur-16-en-18-oic acid methyl ester
|
38315-21-8
|
C21H32O3
|
|
methyl 7-iodoheptanoate
|
38315-25-2
|
C8H15IO2
|
|
17-PHENYL TRINOR PROSTAGLANDIN E2
|
38315-43-4
|
C23H30O5
|
|
16-PHENYL TETRANOR PROSTAGLANDIN E2
|
38315-44-5
|
C22H28O5
|
|
(Z)-7-[(1R,2R,3R,5S)-3,5-DIHYDROXY-2-((E)-(S)-3-HYDROXY-5-PHENYL-PENT-1-ENYL)-CYCLOPENTYL]-HEPT-5-ENOIC ACID METHYL ESTER
|
38315-47-8
|
C24H34O5
|
|
16-phenyl tetranor Prostaglandin F2α
|
38315-48-9
|
C22H30O5
|
|
17-PHENYL TRINOR PROSTAGLANDIN A2
|
38315-51-4
|
C23H28O4
|
|
4-methoxy-alpha-(nitromethyl)benzyl alcohol
|
38316-05-1
|
C9H11NO4
|
|
Rhenium, pentacarbonyl[2,3,3-tetrafluoro-1-(trifluoromethyl)-1-propeny l]-, (OC-6-21)-
|
38317-69-0
|
C9F7O5Re
|
|
(ETHYL-VINYL-PHOSPHINOYL)-BENZENE
|
38318-56-8
|
C10H13OP
|
|
1-Methoxy-2,4,7-trinitronaphthalene
|
38319-13-0
|
C11H7N3O7
|
|
2,6-dicyclohexylcyclohexan-1-one
|
38320-20-6
|
C18H30O
|
|
1-(2-PHENYL-3-INDOLIZINYL)-1-ETHANONE
|
38320-58-0
|
C16H13NO
|
|
(+)-3-(3,4-dimethoxyphenyl)-6-[(5,6-dimethoxyphenethyl)methylamino]hexane-3-carbonitrile
|
38321-02-7
|
C27H38N2O4
|
|
sodium 2-(2-butoxyethoxy)ethanolate
|
38321-18-5
|
C8H17NaO3
|
|
(1R,1'R,3'R,4'S)-9-(β-D-Glucopyranosyloxy)-3,3',4,4'-tetrahydro-4β,4',7,7',9',10-hexahydroxy-1β,1',3α,3'-tetramethyl-5,6'-bi-[1H-naphtho[2,3-c]pyran]-5',10'-dione
|
38321-93-6
|
C36H38O16
|
|
6-[9-(β-D-Glucopyranosyloxy)-3,4-dihydro-4,7,10-trihydroxy-1,3-dimethyl-1H-naphtho[2,3-c]pyran-5-yl]-3,4-dihydro-7,9-dihydroxy-1,3-dimethyl-1H-naphtho[2,3-c]pyran-5,10-dione
|
38322-02-0
|
C36H38O15
|
|
3-Chromanamine, 6,7-dimethyl-, hydrochloride
|
38322-50-8
|
|
|
ethyl 6-chloro-4-oxo-chromene-2-carboxylate
|
38322-69-9
|
C12H9ClO4
|
|
ethyl 6,8-dibromo-4-oxo-chromene-2-carboxylate
|
38322-71-3
|
C12H8Br2O4
|
|
ethyl 8-bromo-6-methyl-4-oxo-chromene-2-carboxylate
|
38322-72-4
|
C13H11BrO4
|
|
ethyl 7-methoxy-4-oxo-chromene-2-carboxylate
|
38322-74-6
|
C13H12O5
|
|
ethyl 8-methyl-6-nitro-4-oxo-chromene-2-carboxylate
|
38322-76-8
|
C13H11NO6
|
|
ethyl 4-sulfanylidenechromene-2-carboxylate
|
38322-77-9
|
C12H10O3S
|